- 623
- 285 403
NCI Scientific Events and Resources
United States
Registrace 5. 12. 2011
The National Cancer Institute (NCI) is the U.S. Government's lead agency for cancer research and is part of the National Institutes of Health (NIH). Videos in this channel feature highlights or full-length presentations from NCI-supported meetings and webinars. Some videos may feature NCI researchers at professional conferences as well.
We welcome your comments; however, we will post them after reviewing them to make sure they conform to our comment policy. Also, we encourage you to read our privacy policy.
We welcome your comments; however, we will post them after reviewing them to make sure they conform to our comment policy. Also, we encourage you to read our privacy policy.
Episode 14. Which Funding Opportunity Should You Pursue? — Grants vs. Contracts
In this episode, NCI SBIR Team Leader Monique Pond and Program Director William Bozza compare and discuss the two main funding mechanisms for biotech innovators, Grants and Contracts. Learn more about the mechanisms:
sbir.cancer.gov/small-business-funding
SBIR DEVELOPMENT CENTER
SBIR Innovation Lab Podcast: sbir.cancer.gov/about/innovation-lab-podcast
SBIR Development Center: sbir.cancer.gov/
LEARN MORE FROM THE NATIONAL CANCER INSTITUTE
Online: www.cancer.gov
By Phone: 1-800-4-CANCER (1-800-422-6237)
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
sbir.cancer.gov/small-business-funding
SBIR DEVELOPMENT CENTER
SBIR Innovation Lab Podcast: sbir.cancer.gov/about/innovation-lab-podcast
SBIR Development Center: sbir.cancer.gov/
LEARN MORE FROM THE NATIONAL CANCER INSTITUTE
Online: www.cancer.gov
By Phone: 1-800-4-CANCER (1-800-422-6237)
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
zhlédnutí: 8
Video
CAR T-Cell Therapy Development in India
zhlédnutí 19Před 2 hodinami
In this seminar, Gaurav Narula, M.D., D.N.B. and Hasmukh Jain, M.D., D.M., discuss the initiation and development of India's first CAR T-cell program. Drs. Narula and Jain cover early collaboration with the National Cancer Institute, development and results of the pediatric and adult trials, and commercial approval and roll-out.
![Curiosity + Strategy = Progress [Special Episode]](http://i.ytimg.com/vi/I80l8K8-AYQ/mqdefault.jpg)
Curiosity + Strategy = Progress [Special Episode]
zhlédnutí 17Před 14 hodinami
In this special episode of Inside Cancer Careers, we hear from Dr. Karen Knudsen, CEO of the American Cancer Society (ACS). Dr. Knudsen shares her career journey into science and the path that led her to her current leadership role at the ACS. She shares her story of finding the right mentor, asking the right questions, and being open to new opportunities. SHOW NOTES Dr. Karen Knudsen: www.can...
Episode 13. Take Your Idea from Academia to Entrepreneurship - Small Business Transition Grant
zhlédnutí 25Před 14 dny
In this episode, NCI SBIR Program Directors William Bozza and Saroj Regmi talk through the benefits of the Small Business Transition Grant for early-career academic scientists interested in transitioning their biotechnology from academic labs into a small business: sbir.cancer.gov/small-business-funding/grants/small-business-transition SBIR DEVELOPMENT CENTER SBIR Innovation Lab Podcast: sbir.c...
12th Annual Symposium on Global Cancer Research: Day 4
zhlédnutí 54Před 14 dny
The 12th Annual Symposium on Global Cancer Research (ASGCR), held virtually May 6-9, 2024, features presentations on cancer research and control programs that address the global burden of cancer. Through scientific sessions and oral abstract presentations, ASGCR creates opportunities for cancer researchers from low resource settings to share their work; provides a venue for the global oncology ...
12th Annual Symposium on Global Cancer Research: Day 3
zhlédnutí 53Před 14 dny
The 12th Annual Symposium on Global Cancer Research (ASGCR), held virtually May 6-9, 2024, features presentations on cancer research and control programs that address the global burden of cancer. Through scientific sessions and oral abstract presentations, ASGCR creates opportunities for cancer researchers from low resource settings to share their work; provides a venue for the global oncology ...
12th Annual Symposium on Global Cancer Research: Day 2
zhlédnutí 46Před 14 dny
The 12th Annual Symposium on Global Cancer Research (ASGCR), held virtually May 6-9, 2024, features presentations on cancer research and control programs that address the global burden of cancer. Through scientific sessions and oral abstract presentations, ASGCR creates opportunities for cancer researchers from low resource settings to share their work; provides a venue for the global oncology ...
12th Annual Symposium on Global Cancer Research: Early Career Investigator Day 1
zhlédnutí 89Před 14 dny
The 12th Annual Symposium on Global Cancer Research (ASGCR), held virtually May 6-9, 2024, features presentations on cancer research and control programs that address the global burden of cancer. Through scientific sessions and oral abstract presentations, ASGCR creates opportunities for cancer researchers from low resource settings to share their work; provides a venue for the global oncology ...
Making an Impact Through Collaboration and Community Engagement
zhlédnutí 19Před 14 dny
In this episode of Inside Cancer Careers, we hear from Dr. Ray DuBois, Director of the MUSC Hollings Cancer Center, Associate Provost for Cancer Programs at MUSC, and Executive Chair of the Mark Foundation for Cancer Research along with Dr. Marvella Ford, Professor in the Department of Public Health Sciences at MUSC and Associate Director of Hollings Cancer Center for Population Sciences and Co...
New Directions in Implementation Science: Integrating Multiple Interventions
zhlédnutí 55Před 21 dnem
The webinar discusses approaches to integrating multiple evidence-based interventions as one strategy; defining two types of integrated interventions, blended and bundled, and describe a schematic for how to assemble blended or bundled interventions with special considerations. Recommended Article Villalobos A, Chambers DA. Advancing the science of integrating multiple interventions by blending...
Episode 12. Funding for Paradigm-Changing Cancer Technologies - NCI SBIR Innovative Concept Award
zhlédnutí 33Před 28 dny
In this episode, NCI SBIR Team Leader Monique Pond invites Program Director William Bozza to dive into the Innovative Concept Award, a funding opportunity that supports biotech innovations with the potential to develop new scientific paradigms focused on pediatric and rare cancers: sbir.cancer.gov/small-business-funding/contracts/innovative-concept-award SBIR DEVELOPMENT CENTER SBIR Innovation ...
Genomic Mutation Analysis in GDC 2.0 - April 22, 2024 GDC Monthly Webinar
zhlédnutí 110Před měsícem
This monthly support webinar helps all types of researchers utilize the cancer genomics data and resources available at NCI’s Genomic Data Commons (GDC). GDC experts will demonstrate how to find and access genomic data, how to use web-based tools, give in-depth explanations of bioinformatics pipelines, and more. GDC 2.0 adopts a "cohort-centric" approach, allowing users to construct custom sets...
Introducing GDC 2.0: A New Cohort-Centric Design - February 23, 2024 GDC Monthly Webinar
zhlédnutí 38Před měsícem
This monthly support webinar helps all types of researchers utilize the cancer genomics data and resources available at NCI’s Genomic Data Commons (GDC). GDC experts will demonstrate how to find and access genomic data, how to use web-based tools, give in-depth explanations of bioinformatics pipelines, and more. GDC 2.0 is a major update to the original GDC Data Portal introduced in 2016. This ...
Planning for the Nation: The President's Cancer Panel
zhlédnutí 24Před měsícem
In this episode of Inside Cancer Careers, we are joined by Dr. Elizabeth Jaffee, the current chair of the President's Cancer Panel, and Ms. Daniela Monterroza, an NCI Communications Fellow who supports the panel. They discuss the panel's responsibility in overseeing the National Cancer Program and National Cancer Plan, emphasizing the importance of patient-centric care, community engagement, an...
Small but Mighty: How Small Changes Can Drive Cancer Cell Progression
zhlédnutí 185Před měsícem
Dr. Hien Dang from Thomas Jefferson University discusses how RNA binding proteins can drive cancer cell progression. Tags: hepatitis, hepatitis C, virus, hepatitis b virus, fatty liver, NAFLD, NASH, MASLD, MASH, metabolic dysfunction associated liver disease, alcoholic hepatitis, alcoholic liver disease, hepatobiliary, cancer, liver, liver disease, liver cancer, fibrosis, cirrhosis, biliary tra...
Episode 11. Partnering Preview: NCI SBIR at the 2024 BIO International Convention
zhlédnutí 37Před měsícem
Episode 11. Partnering Preview: NCI SBIR at the 2024 BIO International Convention
Cultural Transitions: Building a Career in American Science
zhlédnutí 28Před měsícem
Cultural Transitions: Building a Career in American Science
Introduction to the GDC Cohort Level MAF Tool
zhlédnutí 96Před měsícem
Introduction to the GDC Cohort Level MAF Tool
Episode 10. How to Write a Strong Specific Aims Page (Part 2)
zhlédnutí 42Před měsícem
Episode 10. How to Write a Strong Specific Aims Page (Part 2)
A Simplified Mock Peer Review Meeting
zhlédnutí 104Před 2 měsíci
A Simplified Mock Peer Review Meeting
Improving Cancer Detection & Treatment Through Implementation Science & Preclinical Models
zhlédnutí 210Před 2 měsíci
Improving Cancer Detection & Treatment Through Implementation Science & Preclinical Models
Inspiring Creativity through Night Science
zhlédnutí 14Před 2 měsíci
Inspiring Creativity through Night Science
Episode 9. How to Write a Strong Specific Aims Page (Part 1)
zhlédnutí 61Před 2 měsíci
Episode 9. How to Write a Strong Specific Aims Page (Part 1)
Colorectal Cancer Screening, Biology, and Treatment in Nigeria
zhlédnutí 89Před 2 měsíci
Colorectal Cancer Screening, Biology, and Treatment in Nigeria
Advocacy, Mentoring, and Equity in Cancer Research
zhlédnutí 28Před 2 měsíci
Advocacy, Mentoring, and Equity in Cancer Research
Episode 8. How Early Should I Start? A Quick Timeline from Application to Award
zhlédnutí 41Před 2 měsíci
Episode 8. How Early Should I Start? A Quick Timeline from Application to Award
Developing Immunotherapies for Adult and Childhood Cancers
zhlédnutí 210Před 3 měsíci
Developing Immunotherapies for Adult and Childhood Cancers
Together for Tomorrow: Tackling Childhood Cancer
zhlédnutí 19Před 3 měsíci
Together for Tomorrow: Tackling Childhood Cancer
Targeting the Tumor Immune Microenvironment for Biomarker and Therapeutic Discovery in HCC
zhlédnutí 258Před 3 měsíci
Targeting the Tumor Immune Microenvironment for Biomarker and Therapeutic Discovery in HCC
Thank you, this was really helpful!!
voice quality could be improved to have maximal benefits from such outstanding seminar
とうございます」、
Some segments in the video are stamped not adjacent to each other
That was a very informative talk.
I'm very excited to inform everyone that I'm completely cured from HPV recently. I totally got cured from my HPV with a strong and active herbal medicine ordered from a powerful herbalist and it completely fought the virus from my nervous system and i was tested negative after 21 days of using the herbal medicine. I'm here to let you all know that HPV has a complete cure,i got rid of mine with the help of Dr Eguabor and his herbal exploit. Contact him via email: dreguabor@aol.com or WhatsApp +2348107439905
E-mail?
CPTAC-GBM cohort genetic data is not linked to individual case. Making it difficult for researchers to integrate it with radiology.
What if there is other polymorphism that is affecting the outcome (through a different mechanism to the one you are suspecting) and whose genetic segregation is linked (could be due to genetic linkage or biased mating selection) to the polymorphism you are studying, then it could result in confounding and not causation?
Hi, This seems like an increadibly useful tool. Is this available for other cancer types, or are we able to upload CPTAC data into it, or it is limited to ccrcc?
He is making this quite obscure and complicated even for a geneticist!!
Extremely informative
U r the only one who upload video on this topic
🤥
Terrific presentation, thank you!
See analysis of data here: pubpeer.com/publications/D06844F99F3087CCF8EFA4986ED99B
Video doesn't clarify anything.
Please email the GDC help staff at support@nci-gdc.datacommons.io. Your questions and feedback will also help guide the topics we cover in the videos so we encourage you to reach out. Thanks!
Great!
Thank you. Saw Dr. Murray at Jackson Labs CT early 2017..Maine Cancer Genomics Initiative is a most important demonstration of equitable translation of research to practice in genomics. . Thanks. Sorry for technical bumps Dr. Ferro.Distracting; Points made by Geisinger for case finding in State of PA, argue against proliferation of so many "Health Care System" programs..IMO
Great video! Always glad to see professionals on the podium!
So what do I do when in split second after opening the gdc-client quits with "too few argments"" error?
Hi Nikolay, the #NCIGDC Help Desk is available at support@nci-gdc.datacommons.io toassist with questions or issues. See gdc.cancer.gov/support.
I got same error. I could not use it in Ubunto. When you ask someone they just send a link.
Probably not going to get an answer here, but any chance a new video will be made now that the cbioportal has been retired? Cannot for the life of me figure out the GDC Data Portal.
Yes, the GDC is indeed planning a new series of instructional videos! They are a work in progress, however, so to get immediate help with accessing or analyzing data, please email the GDC help staff at support@nci-gdc.datacommons.io. Your questions and feedback will also help guide the topics we cover in the videos so we encourage you to reach out. Thanks!
Nice video ;)
Verry good 😊
very enlightening
This webinar series is a great initiative. With whatever I am seeing and learning, Precision Medicine will surely improve Public Health. But it won't happen overnight. We are talking about complex diseases like cancer, diabetes, etc. It will take several decades before we can expect significant impact from genomics on public health.